Your browser doesn't support javascript.
loading
PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway.
Hou, Shuaibing; Wang, Xiaomin; Guo, Tengxiao; Lan, Yanjie; Yuan, Shengnan; Yang, Shuang; Zhao, Fei; Fang, Aizhong; Liu, Na; Yang, Wanzhu; Chu, Yajing; Jiang, Erlie; Cheng, Tao; Sun, Xiaojian; Yuan, Weiping.
Afiliación
  • Hou S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Wang X; Tianjin Institutes of Health Science, Tianjin, 301600, China.
  • Guo T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. wangxiaomi
  • Lan Y; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of lymphoma, Peking University Cancer Hospital & Institute, Beijing, 100039, China. wangxiaomin@ihcams.ac.cn.
  • Yuan S; Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China. wangxiaomin@ihcams.ac.cn.
  • Yang S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Zhao F; Tianjin Institutes of Health Science, Tianjin, 301600, China.
  • Fang A; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Liu N; Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
  • Yang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Chu Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Jiang E; Tianjin Institutes of Health Science, Tianjin, 301600, China.
  • Cheng T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Sun X; Tianjin Institutes of Health Science, Tianjin, 301600, China.
  • Yuan W; Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Leukemia ; 37(8): 1626-1637, 2023 08.
Article en En | MEDLINE | ID: mdl-37393343
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / FN-kappa B Tipo de estudio: Prognostic_studies Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / FN-kappa B Tipo de estudio: Prognostic_studies Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article